Our researchers are fighting the coronavirus pandemic with innovative approaches. With your donation you can support them in developing drugs and vaccines against the virus or in deciphering the mechanisms of disease development and progression. Here you can find out all about donation opportunities.
Learn more about how the HZI, with its translational focus, will help to facilitate a faster and more targeted approach when it comes to fighting and preventing existing, emerging or recurring infectious diseases.
Here you can find out more about the scientific results of the HZI in the research topics ”Bacterial and Viral Pathogens”, “Immune Response and Interventions” and “Anti-Infectives”.
Around 900 employees in research, administration and infrastructure, and about 220 visiting scientists from 40 different countries are employed at the Helmholtz Centre for Infection Research. To ensure top quality research we need top quality employees. Your creativity and innovative capabilities are the basis for the long-term success of our work. That's why we undertake a great deal to attract the best people to us. Learn more about this.
From 1 July 2023, Prof Josef Penninger takes over the Scientific Management of the Helmholtz Centre for Infection Research (HZI). Here you can find content and background information for media coverage. [read more]
The coronaviruses are a family of viruses that includes a series of very different pathogens. These viruses usually infect mammals, rodents, and birds, but only few coronaviruses adapted to humans. They did this with great success: About one third of all typical "common colds" and some cases of diarrhoea as well are caused by these RNA Viruses, which are the largest of their kind. We have compiled more information about the coronaviruses for you.
With the pathogen SARS-CoV-2, a novel virus that can cause respiratory diseases and pneumonia has been spreading worldwide since the end of 2019. Here we will keep you informed about current developments in research and provide answers to the most important questions.
HomePressPress Releases & News
Results 11 to 20 of total 582
Academy of Sciences in Hamburg recognizes Leendertz’s pioneering achievements in the field of zoonotic infectious diseases
HZI shares statement by the Alliance of Science Organisations in Germany
Unexpected findings on SARS-CoV-2 replication
Interdisciplinary research project wins funding award for citizen science
Innovative malaria project enters next round with GO-Bio initial funding
HZI awards prize for young talents in infection research for the ninth time
Monitoring wildlife species present in specific areas is a critical first step to estimating the risk of transmission of infectious diseases to humans
HIPS director is honoured for his exceptional merit in industrial microbiology and biotechnology
Infection research center headed by one of the world's leading experts on the medical risks of human-animal contact and zoonotic diseases is established in Mecklenburg-Western Pomerania
Interdisciplinary project “Vax2Muc” will receive more than 8.4 million Euro funding from the European Union over five years
You can also find a selection of our press releases on the page of Informationsdienst Wissenschaft